May 09, 2019 / 12:00PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to Axsome Therapeutics' conference call. (Operator Instructions) As a reminder, today's conference call is being recorded.
I would now like to turn the conference over to your host, Mark Jacobson, Senior Vice President of Operations at Axsome Therapeutics. Please go ahead.
Mark Jacobson - Axsome Therapeutics, Inc. - SVP, Operations
Thank you, operator. Good morning and thank you all for joining us on today's conference call. This morning, our press release providing details of the Company's financial results for the first quarter 2019, recent clinical and regulatory achievements, and upcoming milestones crossed the wire a short time ago and is available on our website at axsome.com.
We will begin this call with prepared remarks by Dr. Herriot Tabuteau, Chief Executive Officer; Dr. Cedric O'Gorman, Senior Vice President of Clinical Development and Medical Affairs; and Nick Pizzie, Chief Financial Officer. We will then open the line for questions from analysts. Questions will be taken in the order
Q1 2019 Axsome Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot